Seeking Alpha


Send Message
View as an RSS Feed
View ray69's Comments BY TICKER:
Latest  |  Highest rated
  • Sanofi And Regeneron's Other Potential Blockbuster [View article]
    Go all in on REGN.- its as plain as the hand in front of your face

    Sell CELG and VRTX - put the $ in REGN

    Keep GILD and BIIB andINCY
    May 22, 2015. 10:15 AM | Likes Like |Link to Comment
  • 4 Big Biopharma Deals We Might See In 2015 [View article]
    What goes on at GSK?
    Out of oncology into vaccines! Struggling in respiratory meds.

    This is a red giant that needs another red giant (PFE). Slash research. Halve rep numbers. Milk those good old money makers. Spin off the dregs and invest in startups.

    It has to happen. GSK is dead in the water.

    While it pays the divi I stay but looking for takeover.
    Apr 21, 2015. 12:53 PM | Likes Like |Link to Comment
  • Goldman serves up 19 best stocks to short [View news story]
    Goldman shorts - I buy.

    Somebody please revisit this topic 12 months from now
    Apr 20, 2015. 01:13 PM | 2 Likes Like |Link to Comment
  • Gilead Is A Cash Generation Monster [View article]
    I sold PCYC at $125 and took a massive profit. It now trades at around $250.

    Yet another lesson for me that selling GOOD stocks is bad.

    Of course, I have sold and watched the stocks go down but if I had never sold anything I would have been substantially better off today!
    Apr 20, 2015. 01:10 PM | 2 Likes Like |Link to Comment
  • Banco Santander: A Safe 12% Yield From Europe [View article]
    I think they raised lots of cash from sophisticated US investors about 6 months ago.

    I don't think these guys would have put up the dough without a v.v.convincing story.

    Still no upward action which worries me.

    Anybody know what's really happening?
    Apr 20, 2015. 12:54 PM | Likes Like |Link to Comment
  • Some Pre-Earnings Release Observations About Gilead Sciences [View article]
    In the overall scheme of things users of Sovaldi and the new biotechs now are paying for a future free of the scourge of dread diseases.

    You couldn't find a better example of the value of capitalism. Massive reward drives science for the betterment of all mankind. In a few short years generics will supply wonder drug needs at moderate prices
    Feb 2, 2015. 12:07 PM | 1 Like Like |Link to Comment
  • Why A Merck Clinical Trial May Help Amgen And Regeneron Shares To Set Higher Highs [View article]
    I doubt your numbers re patients requiring expenditure of $10k pa. My generic simvastatin does the job for peanuts - so to speak
    Nov 26, 2014. 12:01 PM | Likes Like |Link to Comment
  • Gilead to license sofosbuvir to Indian drug makers [View news story]
    GOOD - Let Indian licencees protect their (and Gilead's) interests
    Sep 5, 2014. 01:47 PM | Likes Like |Link to Comment
  • Why I Bought Into Monday's Move In Regeneron [View article]
    You can't compare to Sovaldi since it has no competition - yet.

    There are many cholesterol reducers that work more than adequately on the market - now.
    Aug 27, 2014. 09:37 AM | 1 Like Like |Link to Comment
  • Biogen: The Pioneer In The Hemophilia A Market [View article]
    Your net profit margin of 24% is, I suspect a gross underestimate. All research costs have been written off, manufacturing costs mostly written off leaving only marketing costs - initially high-ish, then falling and allowing BIIB to fill their boots along with their partners SOBI
    Jul 30, 2014. 11:58 AM | Likes Like |Link to Comment
  • Pfizer Has It All Wrong, Should Look Into New Viable Acquisitions [View article]
    The author misses the whole point. Celgene and Gilead are fully valued in their own right.

    Both PFE and AZN are worthy but boring on their own.

    AZN plus PFE provides opportunities to reduce marketing and research costs converting them directly into profit via amalgamation.

    This is the right model for old pharma particularly when combined with early investment in startups and MORE particularly when this investment cash comes from reduction in their own research ops.

    Even longer AZN now and might even buy some PFE
    Jul 3, 2014. 10:15 AM | Likes Like |Link to Comment
  • AstraZeneca shareholders upset at rejection of Pfizer offer [View news story]
    AZN shareholders will never see the PFE offer value again. Woodford's judgement that Soroit has transformed its pipeline is pure speculation. Big pharma is dead and should be milked for its momentum. The future belongs to biotechs. Each driven by scientists who have zero problem raising cash to prove their ideas at the frontiers of medicine.
    May 20, 2014. 07:13 AM | Likes Like |Link to Comment
  • ModernGraham Annual Valuation Of Regeneron Pharmaceuticals [View article]
    MG does't work for biotech.

    You would have missed out on PCYC, CELG, GILD etc

    All serious companies not only making money but contributing to the healthcare of the world.

    You may extend your lifespan by virtue of their research
    Apr 17, 2014. 07:20 AM | 1 Like Like |Link to Comment
  • GW Pharmaceuticals: High As A Kite And Too Close To The Sun [View article]
    Baker Bros have a holding- they must have been smoking the stuff when they invested.
    Feb 21, 2014. 02:54 AM | 1 Like Like |Link to Comment
  • Seadrill Expects Forward Growth And Offshore Drilling Industry Strength [View article]
    I'm going to miss the divi.

    My SDRL profit will just about cover my FRO loss

    Thanks for the ride JF!
    Jan 24, 2014. 07:00 AM | Likes Like |Link to Comment